Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the arterial revascularisation therapies study part II (ARTS II)

被引:37
作者
Serruys, PW
Lemos, PA
van Hout, BA
机构
[1] Erasmus Med Ctr, Thoraxctr, NL-3015 GD Rotterdam, Netherlands
[2] Univ Med Ctr, Julius Ctr, Utrecht, Netherlands
关键词
D O I
10.1136/hrt.2003.028811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:995 / 998
页数:4
相关论文
共 8 条
[1]   Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation - Long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up [J].
Degertekin, M ;
Serruys, PW ;
Foley, DP ;
Tanabe, K ;
Regar, E ;
Vos, J ;
Smits, PC ;
van der Giessen, WJ ;
van den Brand, M ;
de Feyter, P ;
Popma, JJ .
CIRCULATION, 2002, 106 (13) :1610-1613
[2]   Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes - Insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry [J].
Lemos, PA ;
Lee, CH ;
Degertekin, M ;
Saia, F ;
Tanabe, K ;
Arampatzis, CA ;
Hoye, A ;
van Duuren, M ;
Sianos, G ;
Smits, PC ;
de Feyter, P ;
van der Giessen, WJ ;
van Domburg, RT ;
Serruys, PW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2093-2099
[3]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[4]   A framework for cost-effectiveness analysis from clinical trial data [J].
O'Hagan, A ;
Stevens, JW .
HEALTH ECONOMICS, 2001, 10 (04) :303-315
[5]   METAANALYSIS OF RANDOMIZED TRIALS COMPARING CORONARY ANGIOPLASTY WITH BYPASS-SURGERY [J].
POCOCK, SJ ;
HENDERSON, RA ;
RICKARDS, AF ;
HAMPTON, JR ;
KING, SB ;
HAMM, CW ;
PUEL, J ;
HUEB, W ;
GOY, JJ ;
RODRIGUEZ, A .
LANCET, 1995, 346 (8984) :1184-1189
[6]   Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. [J].
Serruys, PW ;
Unger, F ;
Sousa, JE ;
Jatene, A ;
Bonnier, HJRM ;
Schonberger, JPAM ;
Buller, N ;
Bonser, R ;
van den Brand, MJB ;
van Herwerden, LA ;
Morel, MAM ;
van Hout, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15) :1117-1124
[7]   ARTS I - the rapamycin eluting stent; ARTS II - the rosy prophecy [J].
Serruys, PW .
EUROPEAN HEART JOURNAL, 2002, 23 (10) :757-759
[8]   COSTS, EFFECTS AND C/E-RATIOS ALONGSIDE A CLINICAL-TRIAL [J].
VANHOUT, BA ;
AL, MJ ;
GORDON, GS ;
RUTEN, FFH .
HEALTH ECONOMICS, 1994, 3 (05) :309-319